Search
for
Sort by
Research 30 of 399
- Effect of PTPN22, FAS/FASL, IL2RA and CTLA4 genetic polymorphisms on the risk of developing alopecia areata: A systematic review of the literature and meta-analysis
- CTLA4 +49AG (rs231775) and CT60 (rs3087243) gene variants are not associated with alopecia areata in a Mexican population from Monterrey Mexico
- 320 An open label clinical trial of Abatacept (CTLA4-Ig) for alopecia areata
- ANALYSIS OF CTLA 4 GENE +49A/G AND CT60 A/G POLYMORPHISMS IN ALOPECIA AREATA PATIENTS
- Studying Cytotoxic T-lymphocyte- Associated Antigen-4 (CTLA-4) gene Polymorphism in a Sample of Iraqi Women with Polycystic Ovarian Syndrome
- Studying Cytotoxic T-lymphocyte- Associated Antigen-4 (CTLA-4) gene Polymorphism in a Sample of Iraqi Women with Polycystic Ovarian Syndrome
- The Cutaneous Side Effects of Selective BRAF Inhibitors and Anti-CTLA4 Agents: the Growing Role of the Dermatologist in the Management of Patients with Metastatic Melanoma
- ODP342 Panhypopituitarism Induced by CTLA-4 and PD-1/PD-L1 Inhibitor Immunotherapy
- Genome-wide association study in alopecia areata implicates both innate and adaptive immunity
- Tregs: Where We Are and What Comes Next?
- Regulatory T Cells: the Many Faces of Foxp3
- Genetic Basis of Alopecia Areata
- Psoriasis is characterized by deficient negative immune regulation compared to transient delayed-type hypersensitivity reactions
- Association of Rs231775 Genetic Variant of Cytotoxic T-lymphocyte Associated Protein 4 with Alopecia Areata Disease in Males: A Case–Control Study
- Immune-Molecular Link between Thyroid and Skin Autoimmune Diseases: A Narrative Review
- Dermatologic adverse events associated with chemotherapy and targeted anticancer therapy
- Clinical and Genetic Aspects of Alopecia Areata: A Cutting Edge Review
- Stepwise acquisition of unique epigenetic signatures during differentiation of tissue Treg cells
- DIAGNOSTIC VALUE OF CHROMOSOMAL MICROARRAY ANALYSIS IN PATIENTS WITH CONGENITAL ANOMALIES AND DYSMORPHIC FEATURES; DETAILS OF TWO NEW PATIENTS WITH 2q33 DELETIONS
- 496 Identification of differentially expressed miRNAs in alopecia areata that target immune-regulatory pathways
- Genetics of Alopecia
- Immune-related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors
- Genes and Immune Response in Alopecia Areata: Review of the Alopecia Areata Research Summit First Day Proceedings
- The Influence of Flightless I: Regeneration versus Wound Healing
- Cutaneous Side Effects of Modern Targeted Therapy and Immunotherapy in Patients with Dermatological Malignancies
- IMMUNE-RELATED SKIN TOXICITIES TO CHECKPOINT INHIBITORS THERAPY
- Discoid Lupus Erythematosus
- An In Situ Chemotherapy Drug Combined with Immune Checkpoint Inhibitor for Chemoimmunotherapy
- The Genetic Architecture of Alopecia Areata
- Taiwanese Dermatological Association consensus on the diagnosis and management of alopecia areata